San Diego, CANCT07502508Now EnrollingIRB Ready

Type 2 Diabetes Clinical Trial in San Diego, CA

Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.

Sponsored by Biomea Fusion Inc.

Quick Self-Assessment

See if you qualify for this San Diego location

Preparing your pre-screening questions…

Expert Care in San Diego

Access type 2 diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 2 diabetes treatment provided free

Apply for This San Diego Location

Check if you qualify for this type 2 diabetes clinical trial in San Diego, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Diego

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Diego site if eligible
  4. 4Begin participation

About This Type 2 Diabetes Study in San Diego

This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D) not achieving glycemic targets despite Ozempic-based therapy.

Sponsor: Biomea Fusion Inc.

Who Can Participate

Inclusion Criteria

Males or females, age ≥18 years and ≤70 years
Have been diagnosed with T2D
Taking Ozempic (semaglutide injection) and have been treated with lifestyle management and 0 to 2 additional antihyperglycemic medications (metformin and/or SGLT2 inhibitor) with a stable dose of all medications for at least 3 months prior to screening
If participants are taking metformin, they must be on a minimum stable dose of ≥500 mg/day
Participants must be on a minimum stable dose of Ozempic ≥0.5 mg/week
Have HbA1c ≥7.5 and ≤9.5%
Have a BMI 25 to 40 kg/m2
Female participants of childbearing potential must have a negative pregnancy test, must be non-lactating, must be willing to have additional pregnancy tests during the study, must agree to the sex and contraception requirements.
Willing and able to provide written, signed informed consent and be willing and able to comply with all study procedures and tests. Key

Exclusion Criteria

Have type 1 diabetes mellitus or a secondary form of diabetes
Have a history of diabetic ketoacidosis or hyperosmolar coma in the 6 months prior to screening
Have a history of severe hypoglycemia (defined by the occurrence of hypoglycemia symptoms requiring the assistance of another person for recovery) in the 6 months prior to screening or a history of hypoglycemia unawareness or poor recognition of hypoglycemic symptoms as judged by the investigator
Have personal or family history (first-degree relative) of MEN1 or MEN2 or medullary thyroid carcinoma
Use of GLP-1 RA other than Ozempic (semaglutide injection), dual GIP/GLP-1 RA, sulfonylureas, meglitinides, thiazolidinediones, alpha glucosidase inhibitor, DPP4I, bile acid sequestrants, dopamaine-2 agonists, amylin, or insulin in the 3 months prior to screening
Have FPG ≥240 mg/dL

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Diego?

Yes, this clinical trial (NCT07502508) has an active research site in San Diego, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 2 Diabetes Treatment Options in San Diego, CA

If you're searching for type 2 diabetes treatment options in San Diego, CA, this clinical trial (NCT07502508) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 2 diabetes clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in San Diego, CA

See all pulmonary embolism clinical trials recruiting in San Diego — not just this study.

Browse Pulmonary Embolism Trials in San Diego →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 2 Diabetes TrialsAll Conditions →

Ready to Join in San Diego?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Diego, CA